AU2002307114A1 - Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders - Google Patents

Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders

Info

Publication number
AU2002307114A1
AU2002307114A1 AU2002307114A AU2002307114A AU2002307114A1 AU 2002307114 A1 AU2002307114 A1 AU 2002307114A1 AU 2002307114 A AU2002307114 A AU 2002307114A AU 2002307114 A AU2002307114 A AU 2002307114A AU 2002307114 A1 AU2002307114 A1 AU 2002307114A1
Authority
AU
Australia
Prior art keywords
quinazoline
integrin
compounds
treatment
mediated disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002307114A
Inventor
Michael J. Costanzo
William J. Hoekstra
Edward C. Lawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2002307114A1 publication Critical patent/AU2002307114A1/en
Abandoned legal-status Critical Current

Links

AU2002307114A 2001-04-09 2002-04-05 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders Abandoned AU2002307114A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/282,648 2001-04-09

Publications (1)

Publication Number Publication Date
AU2002307114A1 true AU2002307114A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
MXPA03007960A (en) Compounds and methods for the treatment of urogenital disorders.
AU2003223380A1 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
PL366636A1 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
IL157145A0 (en) Use of dc23 antagonists for the treatment of neoplastic disorders
GB0128674D0 (en) Treatment of sleep disorders and the like
AU2002363935A1 (en) Composition and method for the treatment of anorectal disorders
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU3899100A (en) Treatment of hyperactivity disorders
AU2002243883A1 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
AU2002363228A1 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
AU2002307114A1 (en) Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
AU2002339673A1 (en) Agonists and antagonists of ryzn for the treatment of metabolic disorders
EP1458403A4 (en) Compositions and methods for the treatment and clinical remission of psoriasis
AU2002256401A1 (en) Heteroaryl ofefinic azacyclic and heteroaryl acetylenic azacyclic compounds for the treatment of cns disorders
AU2002350053A1 (en) Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
AU2002313379A1 (en) Antithrombin for the prevention and therapy of vasculoproliferative disorders
AU2002337618A1 (en) Process and installation for the treatment of biological studies
AU2002309976A1 (en) Composition and method for the treatment of pigmentation disorders
AU2002339971A1 (en) Novel compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use